Glioz contains Temozolomide, an oral alkylating antineoplastic medicine primarily used in the treatment of glioblastoma and other malignant gliomas.

Temozolomide is converted under physiological conditions into an active alkylating compound that damages tumor-cell DNA. This DNA damage interferes with replication and repair mechanisms, helping inhibit the growth and survival of susceptible malignant cells.

Temozolomide is commonly incorporated into treatment protocols with radiotherapy for newly diagnosed glioblastoma and may subsequently be continued as maintenance therapy.

What are Temozolomide Capsules?

Temozolomide Capsules are an oral alkylating chemotherapy medicine used for systemic treatment of certain malignant brain tumors and selected gliomas.

Benefits / Uses

Glioz (Temozolomide Capsules) may be used in treatment protocols for:

• Glioblastoma
• Anaplastic astrocytoma
• Recurrent or progressive malignant glioma
• Other selected malignant gliomas according to specialist oncology protocols

The exact treatment regimen depends on the patient’s diagnosis and clinical condition.

Dosage Guidelines

Temozolomide dosage depends on the diagnosis, treatment phase, body surface area, blood counts, previous treatment, and prescribed oncology regimen.

• Take exactly as prescribed by the treating oncologist.
• Capsules should generally be swallowed whole with water.
• Do not open, crush, or chew the capsules.
• Dosing is commonly once daily during defined treatment cycles.
• In newly diagnosed glioblastoma, Temozolomide may be administered concurrently with radiotherapy and subsequently during maintenance cycles.
• Complete blood counts should be monitored regularly.
• Liver function and other relevant laboratory parameters may also be monitored.
• Dose interruption or adjustment may be required because of significant toxicity.

Wholesale & Supply

Glioz (Temozolomide Capsules) may be supplied for pharmaceutical wholesale and institutional procurement, subject to applicable regulatory requirements and destination-country regulations.

Bulk procurement enquiries may include:

• Available capsule strengths
• Packaging configuration
• Certificate of Analysis (CoA)
• Batch information
• Manufacturing documentation
• Export and shipping documentation

Buying Online

Temozolomide is a prescription anticancer medicine and should be sourced through authorized pharmaceutical distributors, hospitals, pharmacies, or other licensed healthcare channels.

Reviews

Individual responses to Temozolomide vary according to tumor type, molecular characteristics, treatment regimen, disease status, and patient-specific factors. Treatment response and tolerability should be assessed by the treating oncology team.

Quality Assurance

Temozolomide products should undergo appropriate pharmaceutical quality-control testing according to applicable standards, including relevant testing for identity, potency, purity, and formulation-specific quality requirements.

Frequently Asked Questions

What is Glioz used for?

Glioz contains Temozolomide and is primarily used for glioblastoma and other selected malignant gliomas.

What type of medicine is Temozolomide?

Temozolomide is an oral alkylating antineoplastic agent used as chemotherapy for certain brain tumors.

How does Temozolomide work?

Temozolomide causes DNA alkylation, damaging tumor-cell DNA and interfering with DNA replication and cellular survival.

How are Temozolomide Capsules taken?

Temozolomide Capsules should be swallowed whole with water according to the prescribed treatment schedule. They should not be opened, crushed, or chewed.

Can Temozolomide be used with radiotherapy?

Yes. In newly diagnosed glioblastoma, Temozolomide is commonly administered concurrently with radiotherapy and subsequently as maintenance therapy according to the prescribed protocol.

What are the important side effects of Temozolomide?

Potential adverse effects include nausea, vomiting, fatigue, headache, constipation, and bone-marrow suppression, including reduced blood-cell counts. Serious infections and other complications can occur in some patients.

Does Temozolomide require blood-test monitoring?

Yes. Complete blood counts are important during treatment, and liver-function monitoring may also be performed according to the treatment protocol.

Who should prescribe Glioz?

Glioz should be prescribed and managed by a qualified oncologist or other healthcare professional experienced in treating malignant brain tumors.

Conclusion

Glioz (Temozolomide Capsules) is an oral alkylating chemotherapy medicine with an important role in the treatment of glioblastoma and selected malignant gliomas. It works by causing DNA damage in susceptible tumor cells and is frequently incorporated into treatment protocols involving radiotherapy and maintenance therapy. Because Temozolomide can cause significant hematological and other adverse effects, specialist supervision and appropriate laboratory monitoring are essential.